Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • India set to begin the COVID-19 vaccination soon

Govt ICFRE Life Sciences Project Fellow Recruitment | Applications Invited

GLUTEN-FREE PRODUCTS MORE HEALTHY?

India set to begin the COVID-19 vaccination soon
  • BiotechToday
  • India

India set to begin the COVID-19 vaccination soon

bioxone November 7, 2020November 7, 2020

Prama Ghosh, Amity University Kolkata

India is preparing to roll out COVID-19 vaccines with Anganwadi centres, schools, panchayat buildings and other such setups and buildings identified by the state governments as vaccination sites in addition to healthcare facilities. The anti-corona virus inoculation drive would be monitored by the Union health ministry’s digital platform and tracking of the beneficiaries after each job would be done by sending SMSes and generating a QR code. 

In order to avoid duplications and to track beneficiaries, every person in the immunization list would be linked with their Aadhaar cards or any government photo identity if the former is not available. 

eVIN (Electronic Vaccine Intelligence Network), the health ministry’s existing digital platform under UIP (Universal Immunization Programme) will be used to track the  COVID-19 vaccine distribution and delivery, through SMSes which would be sent to recipients informing the time, date and venue of the vaccination. Real-time information on vaccine stocks and storage temperatures across all cold chain points in the country is also provided by the network.

Administration of the vaccine to the priority groups would be made free of cost. Identification of around 30 crore priority beneficiaries has begun who would be immunized on the initial phase. Four categories of people have been demarcated by the government which includes around 1 crore healthcare professionals including doctors, MBBS students, nurses and ASHA workers etc, around two crore frontline workers which include municipal corporation workers, police and armed forces, about 26 crore people aged above 50 and a special category of those below 50 with co-morbidities and requiring specialized care.

Around 40-50 crore doses of COVID-19 vaccine covering 20-25 crore people is estimated to be received and utilized by July next year. State steering committee (SSC) will be set up which will strategize state-specific challenges.

Also read: Chloroquine, Hydroxychloroquine hurts COVID-19 patients with Cardiac Disease

Reference: https://www.livemint.com/science/health/covid-19-vaccine-anganwadi-centres-schools-panchayat-buildings-to-be-used-as-centres-11604663963691.html

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Anganwadi centers anti-corona virus cold chain corona virus covid vaccine india COVID vaccines COVID-19 healthcare centers immunization immunization list inoculation drive priority beneficiaries vaccination sites

One thought on “India set to begin the COVID-19 vaccination soon”

  1. Pingback: DENMARK TO KILL UPTO 17 MILLION MINKS! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Myth-Lysis

GLUTEN-FREE PRODUCTS MORE HEALTHY?

bioxone November 7, 2020

Pratyushee Ghosh, Amity University Kolkata Going gluten-free could also be the most important health trend of the past decade. But there’s confusion over whether gluten is problematic for everybody or simply those with certain medical conditions. Some people must avoid it for health reasons, like those with a disorder or intolerance. However, many within the health and wellness world suggest that everybody should follow a gluten-free diet — no matter whether they’re intolerant […]

GLUTEN-FREE

Related Post

  • BiotechToday
  • World

Interspecies chimerism and cell survival- vulnerable due to cell competition!

bioxone February 14, 2021February 14, 2021

Ayooshi Mitra, Amity University, Kolkata Interspecies chimeras provide a unique platform for discovery and clinical use by probing early embryogenesis and regeneration. Interspecies chimeras are useful through interspecies blastocyst complementation to study human development and disease and also to produce functional human tissues. Cell competition involves a preserved fitness-sensing process during which adjoining less-fit but viable […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

Can a Nose Swab Test For COVID-19 Pierce through your Brain? – It’s NO.

bioxone October 3, 2020October 3, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA A recently reported case was taken where a 40-year-old US women’s brain lining was punctured after her nasal swab test for COVID-19 which ultimately lead to the leakage of the brain fluid through her nose, and eventually putting her at risk of life-threatening infection. The patient had an undetected scarce […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • India

COVID UPDATE: Indian genes against the coronavirus

bioxone September 18, 2020September 18, 2020

-Binayak Das, Team bioXone A team of scientists claims that Indians should be grateful to their genetics, which according to their study is a critical factor in having a comparatively lesser number of deaths from COVID-19 in their populations. They studied the complete DNA data of the ACE2 gene in the X chromosomes from different […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy